Explore Watchlists Pricing

NEUROCRINE BIOSCIENCES INC (NBIX) Income statement

Market cap

$12.9B

P/E ratio

27.4x

Summary Financials

Income statement Balance sheet Cash flow Other

	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12	2025/12
Revenue	77	53	3	-	20	15	162	451	788	-	-	-	-	-	2,861
Revenue growth (%)	-			-	-					-	-	-	-	-	-
Cost of revenue	-	-	-	-	-	-	1	5	-	-	-	-	-	-	52
Research & development	31	37	39	46	81	94	122	161	-	-	-	-	-	-	-
Selling, general & administrative	-	-	-	-	-	-	170	249	354	-	-	-	-	-	1,156
Operating margin (%)				-						-	-	-	-	-
Operating expenses	43	52	53	64	114	162	293	414	716	-	-	-	-	-	2,241
Operating income	34	1	-50	-64	-94	-147	-131	37	72	-	-	-	-	-	619
Income before tax	-	-	-	-	-	-	-	22	47	-	-	-	-	-	705
Pretax margin (%)	-	-	-	-	-	-	-	4.8	5.9	-	-	-	-	-	24.7
Provision for income taxes	-	-	-	-	-	-	-	1	10	-	-	-	-	-	227
Effective tax rate (%)	-	-	-	-	-	-	-			-	-	-	-	-
Net income	38	5	-46	-61	-89	-141	-143	21	37	407	90	155	250	341	479
Net income margin (%)				-						-	-	-	-	-
Earnings per share	0.68	0.08	-0.69	-0.81	-1.05	-1.63	-1.62	0.23	0.4	-	-	-	-	-	4.81
Diluted EPS	0.67	0.08	-0.69	-0.81	-1.05	-1.63	-1.62	0.22	0.39	-	-	-	-	-	4.67